This message contains images. If you don't see images, click here to view.
Click here to advertise in this news brief.

  Mobile version   RSS   Subscribe   Unsubscribe
Home    About    Scholarships    Meetings    Publications    Resources March 8, 2011
ASCLS eNewsBytes
March 8, 2011
ASCLS Quick Links >   Home    About    Scholarships    Meetings    Publications    Resources

Privacy in the era of EHRs: What's the lab's responsibility?
Clinical Laboratory News    Share   Share on FacebookTwitterShare on LinkedinE-mail article
The federal government, as well as many in health care, have touted the move to electronic health records (EHR) as key to boosting more coordinated and efficient care. Starting this year, physicians and hospitals can begin cashing in on government incentives for deploying EHRs, and regulators have made it clear that lab data is a critical component. But while both consumer advocates and regulators have ramped up pressure on providers to maintain the privacy and security of patient health information, at the same time EHRs will ostensibly allow more sharing of information, potentially pulling labs and other providers in two directions. More

Identifying risk factors for triple-negative breast cancer
Medscape Medical News    Share    Share on FacebookTwitterShare on LinkedinE-mail
Two of the largest studies to date looking at triple-negative breast cancer have found that reproductive factors — specifically, pregnancy and multiple childbirth — and obesity and lack of physical activity increase the risk for the disease. This subtype of breast cancer, which is negative for estrogen receptor, progesterone receptor, and HER2, accounts for 10 percent to 20 percent of all breast cancers. More

Honey pot protocells have potential to become a whole
new class of antiviral drugs

Medical News Today    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Researchers from the National Institute of Standards and Technology and the Weill Cornell Medical College have designed artificial "protocells" that can lure, entrap and inactivate a class of deadly human viruses — think decoys with teeth. The technique offers a new research tool that can be used to study in detail the mechanism by which viruses attack cells, and might even become the basis for a new class of antiviral drugs. More

Egg allergy and the influenza vaccine — A new perspective
Medscape Allergy & Clinical Immunology    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The American Academy of Asthma, Allergy, & Immunology issued a paper titled Administering Influenza Vaccine to Egg Allergic Recipients in October 2010. The report offered guidance in the administration of influenza vaccine to egg-allergic individuals, concluding that most of these patients can safely be vaccinated. A follow-up practice parameter published in January 2011 provided more information about the quality of the evidence underpinning recommendations for vaccine administration. More

Qualiris by Stago

Qualiris by Stago is a Web-based External Quality Assessment program used to provide enhanced confidence for your hemostasis testing. Qualiris provides peer-group, result comparisons from a global to a local level. Stago's dedicated experts are available 24/7 to help interpret your results. For more information on Quadfsliris visit

Toenails may hold clue to lung cancer risk
MSNBC    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Your toenails may hold clues to your risk of developing lung cancer, a new study finds. The results show men with high levels of nicotine in their toenails were about 3.5 times more likely to develop lung cancer than those with lower levels of nicotine, regardless of their smoking histories. The findings suggest the detrimental effects of smoking may be underestimated in studies that use only self-reported smoking history to assess lung cancer risk, the researchers said. More

Scientist studies the weapons of salmonella
Infection Control Today    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Some of the most dreaded diseases in the world such as plague, typhoid and cholera are caused by bacteria that have one thing in common: they possess an infection apparatus which is a nearly unbeatable weapon. When attacking a cell of the body, they develop numerous hollow-needle-shaped structures that project from the bacterial surface. Through these needles, the bacteria inject signal substances into the host cells, which reprogram the latter and thereby overcome their defense. More
Related stories:
Recall issued for Skippy reduced-fat peanut butter sold in 16 states

Reprogrammed stem cells are rife with mutations
Technology Review    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Adult cells that have been reprogrammed into stem cells harbor a number of genetic mutations, some of which appear in genes that have been linked to cancer. While scientists don't yet know how this might affect the use of the cells in medicine, they say the findings show that the cells need to be studied much more extensively. More

Scientists use stem cells, skin cells to create brain cells
lost to Alzheimer's

HealthDay News via Bloomberg Businessweek    Share    Share on FacebookTwitterShare on LinkedinE-mail article
In what experts are calling a significant step forward in Alzheimer's research, scientists have for the first time turned human embryonic stem cells and a form of human skin cell into a type of brain cell that's lost to Alzheimer's disease. The disease-induced destruction of these cells, which are called "basal forebrain cholinergic" (BFC) neurons, is key to the progression of Alzheimer's. Their death, say researchers, leads to memory-retrieval problems, one of the most disabling aspects of the illness. Similarly, BFC loss also impairs spatial learning. More

Triturus - True Open Flexibility
As a leader in fully automated immunoassay testing systems, Grifols USA Diagnostic Division’s premier product, the TRITURUS® ELISA System is an open, fully automated, multi-test and multi-batch immunoassay system. Grifols USA is a major distributor of quality IVD ELISA tests for Infectious Disease, Autoimmune Diseases and many other disease states. Grifols’ Diagnostic products take the complexity out of clinical diagnostic testing.

Contact us at 1-800-379-0957.
CellaVision Automates and Standardizes the Manual Differential

CellaVision introduces CellAtlas®, the perfect way to learn the basics of hematology cell morphology. This App for the Apple iPhone and iPod Touch compliments our digital cell morphology portfolio, and is an educational tool to assist in the recognition and classification of blood cells, by utilizing mini-lectures and cell quizzes.
Trust in Cleveland Clinic Laboratories
Cleveland Clinic Laboratories is a full-service, national reference lab dedicated to providing world class care. We have a dedicated staff of more than 1,300 employees, including board-certified subspecialty pathologists, PhDs, technologists, technicians, and support personnel. Cleveland Clinic Laboratories is proud to serve hospitals, outpatient facilities and physician offices worldwide. For more information, please visit
This edition of the ASCLS eNewsBytes was sent to ##Email##. To unsubscribe, click here.

Did someone forward this edition to you? Subscribe here - it's free!


Colby Horton, Vice President of Publishing

Download Media Kit

To contribute news to the ASCLS eNewsBytes, contact Yvette Craig, Senior Content Editor

Recent Issues

  • March 1, 2011
  • Dedicated - Bio-Rad
  • Feb. 22, 2011
  • Feb. 15, 2011
  • Feb. 8, 2011
  •  RSS Feed
    Most popular articles